He Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- Angiogenesis and VEGF in Cancer
- Wnt/β-catenin signaling in development and cancer
Papers in
-
- Cancer-related molecular mechanisms research 18
- MicroRNA in disease regulation 11
- Protease and Inhibitor Mechanisms 9
-
- Circular RNAs in diseases 8
- RNA modifications and cancer 8
- Co-authors
- Joan A. Keiser (7 shared papers)Barbara J.S. Sanderson (3 shared papers)Jing Jing Wang (3 shared papers)Vivek Sivaraman (1 shared paper)Gerard J. Nuovo (1 shared paper)C C Malbon (1 shared paper)Elizabeth Helen Blackburn (2 shared papers)J. Michael Bishop (1 shared paper)
- Journals
- Cancer Cytopathology (9 papers)Biochemical and Biophysical Research Communications (7 papers)Journal of Toxicology and Environmental Health (6 papers)Archives of Pathology & Laboratory Medicine (6 papers)Frontiers in Immunology (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
He Wang
303 papers receiving 9.4k citations
Peers
Comparison fields: 5 of 178
- Cancer Research 1.5k
- Molecular Biology 4.1k
- Microbiology 296
- Aging 82
- Oncology 953
Countries citing papers authored by He Wang
This map shows the geographic impact of He Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He Wang more than expected).
Fields of papers citing papers by He Wang
This network shows the impact of papers produced by He Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He Wang. The network helps show where He Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside He Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 320 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 509 | |
| 2 | 2006 | 465 | |
| 3 | 1997 | 409 | |
| 4 | 1998 | 387 | |
| 5 | 1999 | 333 | |
| 6 | 2016 | 328 | |
| 7 | 2012 | 288 | |
| 8 | 2007 | 203 | |
| 9 | 1996 | 195 | |
| 10 | 1995 | 185 | |
| 11 | 2011 | 143 | |
| 12 | 2018 | 124 | |
| 13 | 2007 | 119 | |
| 14 | 2018 | 116 | |
| 15 | 2007 | 102 | |
| 16 | 1993 | 102 | |
| 17 | 2013 | 101 | |
| 18 | 1996 | 101 | |
| 19 | 2014 | 92 | |
| 20 | Long non-coding RNA MALAT-1 is downregulated in preeclampsia and regulates proliferation, apoptosis, migration and invasion of JEG-3 trophoblast cells. | 2015 | 91 |
About He Wang
He Wang is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Surgery, having authored 320 papers that have together received 9.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (18 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers), MicroRNA in disease regulation (11 papers), Antimicrobial Peptides and Activities (10 papers), Protease and Inhibitor Mechanisms (9 papers), Circular RNAs in diseases (8 papers), RNA modifications and cancer (8 papers) and Antifungal resistance and susceptibility (8 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (4.1k citations), Microbiology (296 citations), Aging (82 citations) and Oncology (953 citations). He Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Joan A. Keiser, Barbara J.S. Sanderson, Jing Jing Wang, Vivek Sivaraman, Gerard J. Nuovo, C C Malbon, Elizabeth Helen Blackburn, J. Michael Bishop, Jing Liu and Jiyue Zhu. Their work appears in journals such as Cancer Cytopathology, Biochemical and Biophysical Research Communications, Journal of Toxicology and Environmental Health, Archives of Pathology & Laboratory Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.